Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells
Open Access
- 6 March 2022
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 19, 101386
Abstract
No abstract availableKeywords
Funding Information
- Congressionally Directed Medical Research Programs
- National Cancer Institute (R01CA200232\u201305)
- National Cancer Institute (W81XWH-16\u20131\u20130025)
- National Cancer Institute (W81XWH-16)
This publication has 37 references indexed in Scilit:
- Cholesterol metabolism and resistance to tamoxifenCurrent Opinion in Pharmacology, 2012
- Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer CellsJournal of Biological Chemistry, 2011
- A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistanceMolecular Cancer Therapeutics, 2008
- Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X ReceptorMolecular Endocrinology, 2007
- Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast CarcinomaClinical Cancer Research, 2007
- What do we know about the mechanisms of aromatase inhibitor resistance?The Journal of Steroid Biochemistry and Molecular Biology, 2006
- Adaptation of Estrogen-regulated Genes in Long-term Estradiol Deprived MCF-7 Breast Cancer CellsBreast Cancer Research and Treatment, 2005
- Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target GenesMolecular Endocrinology, 2005
- Molecular Characterization of Human Acetyl-CoA Synthetase, an Enzyme Regulated by Sterol Regulatory Element-binding ProteinsJournal of Biological Chemistry, 2000
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor βEndocrinology, 1998